HRK and neuroblastoma: We functionally validated HRK suppression by YAP in neuroblastoma cell lines, showed that HRK is suppressed when YAP is increased in relapsed tumors, and demonstrated that following chemotherapy treatment of PDXs in vivo, YAP expression increases while HRK expression decreases [51].